BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain tumor trial combines radiation with targeted drugs and immunotherapy
Disease control OngoingThis study tests whether adding focused radiation (stereotactic radiosurgery) to a combination of targeted drugs (binimetinib and encorafenib) and an immunotherapy (pembrolizumab) can better control melanoma that has spread to the brain. It includes 10 adults with a specific gene…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
Scientists hunt for hidden genetic clues behind lung cancer drug resistance.
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why certain lung cancers become resistant to targeted drugs called tyrosine kinase inhibitors (TKIs). Researchers will analyze tumor tissue from 40 patients whose cancer has stopped responding to treatment. They hope to find new genetic changes that cause resi…
Matched conditions: BRAF V600 MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 03, 2026 12:02 UTC